Project Details
Description
Rheumatoid arthritis and psoriatic arthritis can cause severe pain, joint destruction, disability and early death. Biologic drugs can improve these arthritis health outcomes but may also have serious side effects, are very costly and are not cures. Drug-free remission is the next best outcome. This trial aims to identify the optimum dosing strategies for safer and more efficient biologic drug use to help more people with rheumatoid and psoriatic arthritis achieve a drug-free remission.
Short title | MRFF 2021 |
---|---|
Acronym | USYD Led |
Status | Active |
Effective start/end date | 1/06/21 → 31/05/25 |